It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Future multi-year crewed planetary missions will motivate advances in aerospace nutrition and telehealth. On Earth, the Human Cell Atlas project aims to spatially map all cell types in the human body. Here, we propose that a parallel Human Cell Space Atlas could serve as an openly available, global resource for space life science research. As humanity becomes increasingly spacefaring, high-resolution omics on orbit could permit an advent of precision spaceflight healthcare. Alongside the scientific potential, we consider the complex ethical, cultural, and legal challenges intrinsic to the human space omics discipline, and how philosophical frameworks may benefit from international perspectives.
High-resolution omics data have facilitated the ongoing Human Cell Atlas project. In this Perspective, Rutter and colleagues propose that a parallel Human Cell Space Atlas initiative would provide a platform for spaceflight-associated research and healthcare.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details










1 University of Tsukuba, Transborder Medical Research Center, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); University of Tsukuba, Department of Genome Biology, Institute of Medicine, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); University of Glasgow, School of Chemistry, Glasgow, UK (GRID:grid.8756.c) (ISNI:0000 0001 2193 314X)
2 University of Nottingham, School of Medicine, Derby, UK (GRID:grid.4563.4) (ISNI:0000 0004 1936 8868)
3 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The WorldQuant Initiative for Quantitative Prediction, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
4 Centro de Investigaciones Biológicas “Margarita Salas” (CSIC), Madrid, Spain (GRID:grid.418281.6) (ISNI:0000 0004 1794 0752)
5 Atal Bihari Vajpayee Institute of Medical Sciences & Dr. Ram Manohar Lohia Hospital, Department of Biochemistry, New Delhi, India (GRID:grid.414117.6) (ISNI:0000 0004 1767 6509)
6 Russian Academy of Sciences, Department of Immunology and Microbiology, Institute for the Biomedical Problems, Moscow, Russia (GRID:grid.4886.2) (ISNI:0000 0001 2192 9124)
7 NASA Ames Research Center, Space Biosciences Division, Moffett Field, USA (GRID:grid.419075.e) (ISNI:0000 0001 1955 7990)
8 Department of Human Factors and Behavioral Neurobiology, Embry-Riddle Aeronautical University, Daytona Beach, USA (GRID:grid.255501.6) (ISNI:0000 0001 0561 4552)
9 University of Wisconsin-Madison, Department of Botany, Madison, USA (GRID:grid.14003.36) (ISNI:0000 0001 2167 3675)
10 The Children’s Hospital of Philadelphia, Department of Biomedical and Health Informatics, Philadelphia, USA (GRID:grid.239552.a) (ISNI:0000 0001 0680 8770); University of Pennsylvania, Department of Pediatrics, Perelman School of Medicine, Philadelphia, USA (GRID:grid.25879.31) (ISNI:0000 0004 1936 8972)
11 University of Tübingen, Institute of Medical Genetics and Applied Genomics, Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447); University of Tübingen, NGS Competence Center Tübingen (NCCT), Tübingen, Germany (GRID:grid.10392.39) (ISNI:0000 0001 2190 1447); yuri GmbH, Meckenbeuren, Germany (GRID:grid.10392.39)
12 University of Nottingham, School of Medicine, Derby, UK (GRID:grid.4563.4) (ISNI:0000 0004 1936 8868); Ohio University, Ohio Musculoskeletal and Neurological Institute (OMNI), Heritage College of Osteopathic Medicine, Athens, USA (GRID:grid.20627.31) (ISNI:0000 0001 0668 7841)
13 University of Tsukuba, Transborder Medical Research Center, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728); University of Tsukuba, Department of Genome Biology, Institute of Medicine, Tsukuba, Japan (GRID:grid.20515.33) (ISNI:0000 0001 2369 4728)
14 Weill Cornell Medicine, Department of Physiology and Biophysics, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The WorldQuant Initiative for Quantitative Prediction, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643); Weill Cornell Medicine, The Feil Family Brain and Mind Research Institute, New York, USA (GRID:grid.471410.7) (ISNI:0000 0001 2179 7643)
15 KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746)